| Drug Type Chemical drugs | 
| Synonyms NAV1.1 openers(Xenon), XPC 1418, XPC1418 | 
| Target | 
| Action modulators | 
| Mechanism Nav1.1 modulators(Sodium channel protein type I alpha subunit modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Epilepsies, Myoclonic | Preclinical | Canada  | 06 Jul 2024 | |
| Seizures | Preclinical | Canada  | 03 Dec 2023 | 





